Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7344) 7344
Newspaper Article (16) 16
Streaming Video (12) 12
Book Chapter (7) 7
Book / eBook (5) 5
Dissertation (4) 4
Magazine Article (3) 3
Publication (3) 3
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6099) 6099
science & technology (5977) 5977
covid-19 (5236) 5236
life sciences & biomedicine (5179) 5179
sars-cov-2 (4736) 4736
pandemics (3807) 3807
coronaviruses (3475) 3475
severe acute respiratory syndrome coronavirus 2 (2599) 2599
female (1985) 1985
severe acute respiratory syndrome (1971) 1971
immunology (1942) 1942
male (1847) 1847
health aspects (1582) 1582
viruses (1549) 1549
animals (1533) 1533
betacoronavirus (1442) 1442
viral diseases (1386) 1386
middle aged (1344) 1344
adult (1327) 1327
infections (1312) 1312
infectious diseases (1241) 1241
coronavirus infections - epidemiology (1228) 1228
pneumonia, viral - epidemiology (1186) 1186
coronavirus infections - virology (1151) 1151
coronavirus infections - immunology (1134) 1134
pneumonia, viral - virology (1069) 1069
pneumonia, viral - immunology (1037) 1037
aged (1022) 1022
epidemics (972) 972
disease transmission (939) 939
betacoronavirus - immunology (898) 898
microbiology (898) 898
coronavirus (861) 861
sars virus - immunology (803) 803
vaccines (799) 799
virology (786) 786
science & technology - other topics (777) 777
multidisciplinary sciences (749) 749
antibodies (721) 721
proteins (720) 720
patients (717) 717
coronavirus infections - prevention & control (715) 715
coronavirus infections - diagnosis (702) 702
public health (701) 701
pandemics - prevention & control (698) 698
respiratory diseases (657) 657
antibodies, viral - blood (639) 639
medical research (628) 628
pneumonia, viral - prevention & control (624) 624
pneumonia, viral - diagnosis (622) 622
covid-19 - immunology (614) 614
covid‐19 (582) 582
risk factors (570) 570
covid-19 - virology (561) 561
analysis (546) 546
review (540) 540
mortality (536) 536
immune response (519) 519
sars-cov-2 - immunology (515) 515
inflammation (513) 513
biochemistry & molecular biology (508) 508
epidemiology (508) 508
mice (506) 506
medicine, research & experimental (501) 501
research & experimental medicine (499) 499
covid-19 - epidemiology (492) 492
severe acute respiratory syndrome - immunology (489) 489
severe acute respiratory syndrome - virology (477) 477
adolescent (476) 476
antibodies, viral - immunology (471) 471
sars (466) 466
coronavirus infections - transmission (460) 460
research (450) 450
pneumonia (449) 449
sars virus - genetics (445) 445
betacoronavirus - pathogenicity (444) 444
coronavirus infections - complications (442) 442
pneumonia, viral - complications (441) 441
pneumonia, viral - transmission (437) 437
young adult (431) 431
betacoronavirus - isolation & purification (429) 429
aged, 80 and over (421) 421
cell biology (420) 420
betacoronavirus - genetics (414) 414
child (414) 414
medicine, experimental (410) 410
abridged index medicus (405) 405
cytokines (405) 405
laboratories (405) 405
biological and medical sciences (403) 403
medicine and health sciences (402) 402
sars‐cov‐2 (398) 398
coronavirus infections - drug therapy (382) 382
coronavirus infections - therapy (380) 380
severity of illness index (380) 380
viral vaccines - immunology (375) 375
covid-19 testing (368) 368
pneumonia, viral - therapy (367) 367
hospitals (366) 366
coronavirus infections (364) 364
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7328) 7328
Chinese (101) 101
Japanese (11) 11
Spanish (9) 9
German (8) 8
Portuguese (8) 8
Russian (6) 6
French (5) 5
Danish (1) 1
Hungarian (1) 1
Italian (1) 1
Norwegian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text A human monoclonal antibody blocking SARS-CoV-2 infection
by Wang, C and Li, W and bek, Dubravka and Okba, Nisreen and Haperen, Rien and Osterhaus, Albert and Kuppeveld, Frank and Haagmans, Bart and Grosveld, Frank and Bosch, Berend Jan
Nature communications, ISSN 2041-1723, 05/2020, Volume 11, Issue 1, pp. 2251 - 2251
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Coronavirus Infections - prevention & control | SARS Virus - immunology | Antibodies, Viral - pharmacology | Receptors, Virus - metabolism | Coronavirus Infections - drug therapy | Epitopes, B-Lymphocyte - chemistry | Humans | Pandemics - prevention & control | Pneumonia, Viral - drug therapy | Antibody Affinity - immunology | Epitopes, B-Lymphocyte - immunology | Betacoronavirus - immunology | COVID-19 | Antibodies, Neutralizing - immunology | SARS-CoV-2 | Betacoronavirus - chemistry | Protein Binding - drug effects | Peptidyl-Dipeptidase A - metabolism | Conserved Sequence | Inhibitory Concentration 50 | Spike Glycoprotein, Coronavirus - immunology | Protein Domains - immunology | Vero Cells | Antibodies, Monoclonal - immunology | Chlorocebus aethiops | Antibodies, Monoclonal - pharmacology | Betacoronavirus - drug effects | Models, Molecular | SARS Virus - drug effects | Antibodies, Neutralizing - pharmacology | Cross Reactions - immunology | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | SARS Virus - chemistry | Angiotensin-Converting Enzyme 2 | Animals | Peptidyl-Dipeptidase A - chemistry | Receptors, Virus - chemistry | Coronavirus Infections - virology | Pneumonia, Viral - prevention & control | Antibodies, Viral - immunology | In Vitro Techniques | Pneumonia, Viral - virology | Spike Glycoprotein, Coronavirus - chemistry | Epidemics | Cell culture | Health services | Medical treatment | Severe acute respiratory syndrome | Viral diseases | Viruses | Coronaviruses | Vaccines | Severe acute respiratory syndrome coronavirus 2 | Respiratory diseases | Neutralizing | Monoclonal antibodies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
by Walls, Alexandra C and Xiong, Xiaoli and Park, Young-Jun and Tortorici, M. Alejandra and Snijder, Joost and Quispe, Joel and Cameroni, Elisabetta and Gopal, Robin and Dai, Mian and Lanzavecchia, Antonio and Zambon, Maria and Rey, Félix A and Corti, Davide and Veesler, David
Cell (Cambridge), ISSN 0092-8674, 02/2019, Volume 176, Issue 5, pp. 1026 - 1039.e15
glycoproteomics | spike glycoprotein | SARS-CoV | coronavirus | neutralizing antibodies | MERS-CoV | N-linked glycosylation | class I fusion protein | membrane fusion | Biochemistry, Genetics and Molecular Biology(all) | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | SARS Virus - immunology | Chlorocebus aethiops | Spike Glycoprotein, Coronavirus - metabolism | Immunity, Humoral - immunology | Receptors, Virus - metabolism | Humans | Molecular Mimicry - immunology | Coronavirus Infections - immunology | Middle East Respiratory Syndrome Coronavirus - immunology | SARS Virus - metabolism | Virus Internalization | Coronavirus - immunology | Middle East Respiratory Syndrome Coronavirus - metabolism | Spike Glycoprotein, Coronavirus - physiology | Antibodies, Neutralizing - immunology | Animals | Coronavirus - metabolism | HEK293 Cells | Protein Binding | Antibodies, Viral - immunology | Vero Cells | Antibodies, Monoclonal - immunology | Spike Glycoprotein, Coronavirus - ultrastructure | Viral antibodies | Respiratory tract infections | Analysis | Physiological aspects | Antibodies | Glycoproteins | Mass spectrometry | Health aspects | Index Medicus | Antibodies, Neutralizing | Coronavirus Infections | Antibodies, Monoclonal | Antibodies, Viral | Middle East Respiratory Syndrome Coronavirus | Spike Glycoprotein, Coronavirus | Life Sciences | SARS Virus | Molecular Mimicry | Coronavirus | Immunity, Humoral | Receptors, Virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
by Ou, Xiuyuan and Liu, Yan and Lei, Xiaobo and Li, Pei and Mi, Dan and Ren, Lili and Guo, Li and Guo, Ruixuan and Chen, Ting and Hu, Jiaxin and Xiang, Zichun and Mu, Zhixia and Chen, Xing and Chen, Jieyong and Hu, Keping and Jin, Qi and Wang, Jianwei and Qian, Zhaohui
Nature communications, ISSN 2041-1723, 12/2020, Volume 11, Issue 1, pp. 1620 - 1620
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Broadly Neutralizing Antibodies - immunology | SARS Virus - immunology | Pandemics | Calcium Channels - metabolism | Receptors, Virus - metabolism | Humans | Protein Multimerization | Severe Acute Respiratory Syndrome - immunology | Neutralization Tests | Cathepsin L - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Virus Internalization | Betacoronavirus - immunology | COVID-19 | Cell Fusion | Endocytosis | SARS-CoV-2 | Betacoronavirus - chemistry | Betacoronavirus - physiology | HEK293 Cells | Peptidyl-Dipeptidase A - metabolism | Giant Cells - physiology | Protein Domains | Spike Glycoprotein, Coronavirus - immunology | Cathepsins - antagonists & inhibitors | Spike Glycoprotein, Coronavirus - metabolism | Trypsin - metabolism | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Cross Reactions | Angiotensin-Converting Enzyme 2 | Cathepsins - metabolism | Antibodies, Viral - immunology | Spike Glycoprotein, Coronavirus - chemistry | Cathepsin L | Spike protein | Cross-reactivity | Severe acute respiratory syndrome | Viral diseases | Antibodies | Viruses | Glycoproteins | Vaccines | Coronaviruses | Drug development | Angiotensin-converting enzyme 2--ACE2 | Immunosuppressive agents | Severe acute respiratory syndrome coronavirus 2 | Proteins | Angiotensin | Spike glycoprotein | Neutralization | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine
by Pregelj, Lisette and Hine, Damian C and Oyola-Lozada, Maria G and Munro, Trent P
Trends in biotechnology (Regular ed.), ISSN 0167-7799, 09/2020, Volume 38, Issue 9, pp. 943 - 947
COVID-19 | innovation speed | vaccine development | regulation | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Betacoronavirus - pathogenicity | United States - epidemiology | Severe Acute Respiratory Syndrome - epidemiology | Hemorrhagic Fever, Ebola - prevention & control | Humans | Pandemics - prevention & control | Severe Acute Respiratory Syndrome - immunology | Middle East Respiratory Syndrome Coronavirus - immunology | Betacoronavirus - immunology | SARS-CoV-2 | Hemorrhagic Fever, Ebola - virology | Influenza, Human - virology | Zika Virus - pathogenicity | Ebola Vaccines - administration & dosage | Hemorrhagic Fever, Ebola - epidemiology | Coronavirus Infections - immunology | SARS Virus - pathogenicity | Viral Vaccines - administration & dosage | Coronavirus Infections - virology | Influenza Vaccines - biosynthesis | COVID-19 Vaccines | Government Regulation | Zika Virus Infection - immunology | Influenza, Human - prevention & control | Coronavirus Infections - prevention & control | Influenza A Virus, H1N1 Subtype - immunology | SARS Virus - immunology | Influenza Vaccines - administration & dosage | Severe Acute Respiratory Syndrome - virology | Ebolavirus - pathogenicity | Ebolavirus - immunology | Ebolavirus - drug effects | Zika Virus Infection - virology | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Global Health - trends | Hemorrhagic Fever, Ebola - immunology | Zika Virus Infection - prevention & control | Influenza A Virus, H1N1 Subtype - genetics | Ebola Vaccines - biosynthesis | Viral Vaccines - biosynthesis | Zika Virus - immunology | Betacoronavirus - drug effects | Europe - epidemiology | Middle East Respiratory Syndrome Coronavirus - drug effects | SARS Virus - drug effects | Influenza, Human - epidemiology | Zika Virus - drug effects | Drug Approval - organization & administration | Pneumonia, Viral - immunology | Middle East Respiratory Syndrome Coronavirus - pathogenicity | Severe Acute Respiratory Syndrome - prevention & control | Zika Virus Infection - epidemiology | Pneumonia, Viral - prevention & control | Pneumonia, Viral - virology | Influenza, Human - immunology | Business schools | Vaccines | Health aspects | Nanotechnology | Vector-borne diseases | Epidemics | Pandemics | Swine flu | Viral diseases | Outbreaks | Viruses | Coronaviruses | Epidemiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide
by Barquera, Rodrigo and Collen, Evelyn and Di, Da and Buhler, Stéphane and Teixeira, João and Llamas, Bastien and Nunes, José M and Sanchez‐Mazas, Alicia
HLA : immune response genetics, ISSN 2059-2302, 09/2020, Volume 96, Issue 3, pp. 277 - 298
influenza | peptide‐binding predictions | natural selection | COVID‐19 | HIV | SARS‐CoV‐2 | coronavirus | Indigenous Americans | HLA population genetics | COVID-19 | SARS-CoV-2 | peptide-binding predictions | Severe Acute Respiratory Syndrome - epidemiology | HIV Infections - epidemiology | Humans | Peptides - genetics | Severe Acute Respiratory Syndrome - immunology | HLA Antigens - genetics | Middle East Respiratory Syndrome Coronavirus - immunology | Betacoronavirus - immunology | Americas - epidemiology | HIV Infections - immunology | Influenza, Human - virology | Amino Acid Sequence | Viral Proteins - chemistry | HIV Infections - virology | Peptides - immunology | Computational Biology | HLA Antigens - immunology | Viral Proteins - genetics | Influenza A Virus, H3N2 Subtype - immunology | Coronavirus Infections - immunology | Coronavirus Infections - virology | Middle East Respiratory Syndrome Coronavirus - genetics | Kinetics | Betacoronavirus - genetics | Influenza A Virus, H1N1 Subtype - immunology | SARS Virus - immunology | Africa - epidemiology | Pandemics | Severe Acute Respiratory Syndrome - virology | Viral Proteins - immunology | Influenza A Virus, H3N2 Subtype - genetics | Influenza A Virus, H7N9 Subtype - immunology | SARS Virus - genetics | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Influenza A Virus, H1N1 Subtype - genetics | Peptides - chemistry | Europe - epidemiology | Influenza, Human - epidemiology | HIV-1 - genetics | HLA Antigens - chemistry | Pneumonia, Viral - immunology | Australia - epidemiology | Asia - epidemiology | HIV-1 - immunology | HLA Antigens - classification | Protein Binding | Influenza A Virus, H7N9 Subtype - genetics | Pneumonia, Viral - virology | Influenza, Human - immunology | Pathology | Immunology | Life Sciences & Biomedicine | Science & Technology | Cell Biology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
by Ziegler, Carly G.K and Allon, Samuel J and Nyquist, Sarah K and Mbano, Ian M and Miao, Vincent N and Tzouanas, Constantine N and Cao, Yuming and Yousif, Ashraf S and Hauser, Blake M and Feldman, Jared and Muus, Christoph and Wadsworth, Marc H and Kazer, Samuel W and Hughes, Travis K and Doran, Benjamin and Gatter, G. James and Vukovic, Marko and Taliaferro, Faith and Guo, Zhiru and Wang, Jennifer P and Gras, Delphine and Plaisant, Magali and Ansari, Meshal and Adler, Heiko and Sucre, Jennifer M.S and Taylor, Chase J and Lin, Brian and Waghray, Avinash and Mitsialis, Vanessa and Dwyer, Daniel F and Buchheit, Kathleen M and Boyce, Joshua A and Barrett, Nora A and Laidlaw, Tanya M and Carroll, Shaina L and Colonna, Lucrezia and Peterson, Christopher W and Yu, Alison and Winchell, Caylin G and Lin, Philana Ling and Bingle, Colin D and Snapper, Scott B and Theis, Fabian J and Schiller, Herbert B and Zaragosi, Laure-Emmanuelle and Barbry, Pascal and Leslie, Alasdair and Kiem, Hans-Peter and Fortune, Sarah M and Berger, Bonnie and Finberg, Robert W and Garber, Manuel and Lingwood, Daniel and Shalek, Alex K and Ordovas-Montanes, Jose and Banovich, Nicholas and Barbry, Pascal and Desai, Tushar and Duong, Thu Elizabeth and Eickelberg, Oliver and Falk, Christine and Farzan, Michael and Glass, Ian and Haniffa, Muzlifah and Hung, Deborah and Kaminski, Naftali and Krasnow, Mark and Kropski, Jonathan A and Kuhnemund, Malte and Lafyatis, Robert and Lee, Haeock and Leroy, Sylvie and Lundeberg, Joakim and Meyer, Kerstin and Misharin, Alexander and Nawijn, Martijn and Nikolic, Marko Z and Ordovas-Montanes, Jose and Pe’er, Dana and Quake, Stephen and Rajagopal, Jay and Tata, Purushothama Rao and Rawlins, Emma L and Regev, Aviv and Rosen, Orit and Saeb-Parsy, Kourosh and Samakovlis, Christos and Schiller, Herbert and Schultze, Joachim L and Shalek, Alex K and Shepherd, Douglas and Sun, Xin and Theis, Fabian and Tsankov, Alexander and von Papen, Michael and Whitsett, Jeffrey and Xavier, Ramnik and Xu, Yan and Zaragosi, Laure-Emmanuelle and Zhang, Kun and HCA Lung Biological Network and HCA Lung Biol Network and HCA Lung Biological Network. Electronic address: lung-network@humancellatlas.org
Cell (Cambridge), ISSN 0092-8674, 05/2020, Volume 181, Issue 5, pp. 1016 - 1035.e19
COVID-19 | influenza | ACE2 | mouse | scRNA-seq | SARS-CoV-2 | non-human primate | interferon | ISG | human | Up-Regulation | Pandemics | Humans | Macaca mulatta | HIV Infections/immunology | Influenza, Human/immunology | Enterocytes/immunology | Tuberculosis/immunology | Interferon Type I/immunology | Serine Endopeptidases/metabolism | Single-Cell Analysis | Child | Cell Line | Peptidyl-Dipeptidase A/genetics | Betacoronavirus/physiology | Cells, Cultured | Nasal Mucosa/cytology | Coronavirus Infections/virology | Lung/cytology | Animals | Pneumonia, Viral/virology | Receptors, Virus/genetics | Mycobacterium tuberculosis | Alveolar Epithelial Cells/immunology | Adolescent | Mice | Goblet Cells/immunology | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Enterocytes - metabolism | Receptors, Virus - genetics | Interferon Type I - immunology | Lung - cytology | Alveolar Epithelial Cells - immunology | Goblet Cells - immunology | HIV Infections - immunology | Peptidyl-Dipeptidase A - genetics | Betacoronavirus - physiology | Peptidyl-Dipeptidase A - metabolism | Interferon Type I - metabolism | Lung - pathology | Alveolar Epithelial Cells - metabolism | Goblet Cells - metabolism | Enterocytes - immunology | Tuberculosis - immunology | Angiotensin-Converting Enzyme 2 | Coronavirus Infections - virology | Nasal Mucosa - immunology | Nasal Mucosa - cytology | Serine Endopeptidases - metabolism | Pneumonia, Viral - virology | Influenza, Human - immunology | Interferon | Biological response modifiers | Health aspects | Analysis | Index Medicus | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
by Yuan, Meng and Wu, Nicholas C and Zhu, Xueyong and Lee, Chang-Chun D and So, Ray T. Y and Lv, Huibin and Mok, Chris K. P and Wilson, Ian A and Argonne National Lab. (ANL), Argonne, IL (United States)
Science (American Association for the Advancement of Science), ISSN 0036-8075, 05/2020, Volume 368, Issue 6491, pp. 630 - 633
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | SARS Virus - immunology | Protein Interaction Domains and Motifs - immunology | Receptors, Virus - metabolism | Crystallography, X-Ray | Betacoronavirus - immunology | Epitopes - immunology | Antibodies, Neutralizing - immunology | SARS-CoV-2 | Betacoronavirus - chemistry | Peptidyl-Dipeptidase A - metabolism | Protein Domains | Spike Glycoprotein, Coronavirus - immunology | Binding Sites | Receptors, Coronavirus | Amino Acid Sequence | Models, Molecular | Antibody Affinity | Antigens, Viral - chemistry | SARS Virus - chemistry | Cross Reactions | Angiotensin-Converting Enzyme 2 | Antigens, Viral - immunology | Peptidyl-Dipeptidase A - chemistry | Receptors, Virus - chemistry | Antibodies, Neutralizing - chemistry | Antibodies, Viral - chemistry | Antibodies, Viral - immunology | Protein Conformation | Epitopes - chemistry | Spike Glycoprotein, Coronavirus - chemistry | Pandemics | Severe acute respiratory syndrome | Viral diseases | Antibodies | Viruses | Vaccines | Coronaviruses | Glycan | Antibody response | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Domains | Proteins | Receptors | Antigenicity | Neutralizing | Respiratory diseases | Modelling | Binding sites | Recognition | Crystal structure | Index Medicus | 60 APPLIED LIFE SCIENCES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights